5 results match your criteria: "General Hospital of Thoracic Diseases SOTIRIA[Affiliation]"

Candida-related infections have increased dramatically in recent years, particularly in severely sick or immunocompromised individuals. Furthermore, the discovery of  in 2009 as a fungus resistant to numerous antifungal treatments has increased its significance. This microorganism is linked to high transmission rates among hospitalized patients, resulting in life-threatening infections and complications.

View Article and Find Full Text PDF

Background: Diabetes is a chronic disease that may be related to various periods of an individual's life.

Aim: The aim of the present study is the investigation of the existence of depression and anxiety among patients suffering from type 2 diabetes as well as the factors that influence these variables (depression and anxiety).

Materials And Methods: The Hospital Anxiety and Depression Scale (HADS) for mental health assessment was used in the context of the collection of the research data.

View Article and Find Full Text PDF

The medical literature defines a chronic physical disease as any organic disorder that lasts more than three months or that entails a period of hospitalization of more than of a month, which restricts an individual's daily abilities or behaviors and causes changes to their social functions [...

View Article and Find Full Text PDF

Chronic diseases, such as childhood diabetes mellitus (DM), are a complex and continuous struggle as well as a great challenge both for the children who face the disease and for their parents. DM is characterized by the complex management of therapeutic treatments, thus causing physical and psychological complications infamily members. There are many families who, upon hearing the diagnosis of their child with DM, stand still in front of these new facts as their lives change.

View Article and Find Full Text PDF

Background: The cancer vaccine Vx-001, which targets the universal tumour antigen TElomerase Reverse Transcriptase (TERT), can mount specific Vx-001/TERT CD8 + cytotoxic T cells; this immune response is associated with improved overall survival (OS) in patients with advanced/metastatic non-small cell lung cancer (NSCLC).

Methods: A randomised, double blind, phase 2b trial, in HLA-A*201-positive patients with metastatic, TERT-expressing NSCLC, who did not progress after first-line platinum-based chemotherapy were randomised to receive either Vx-001 or placebo. The primary endpoint of the trial was OS.

View Article and Find Full Text PDF